Arena Pharmaceuticals Inc EBITDA margin
Was ist das EBITDA margin von Arena Pharmaceuticals Inc?
EBITDA margin von Arena Pharmaceuticals Inc ist -1,015,500.00%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Arena Pharmaceuticals Inc
Was macht Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Unternehmen mit ebitda margin ähnlich Arena Pharmaceuticals Inc
- AZ Leasing SPA hat EBITDA margin von -1,251,900.00%
- Pacgold hat EBITDA margin von -1,113,809.64%
- Altan Nevada Minerals hat EBITDA margin von -1,103,594.44%
- MetalsTech hat EBITDA margin von -1,065,856.86%
- Avalon Advanced Materials hat EBITDA margin von -1,039,102.87%
- Raiden Resources hat EBITDA margin von -1,035,879.18%
- Arena Pharmaceuticals Inc hat EBITDA margin von -1,015,500.00%
- Talon Metals hat EBITDA margin von -1,008,048.83%
- Resource Base Ltd hat EBITDA margin von -931,507.14%
- Zinc of Ireland NL hat EBITDA margin von -893,008.00%
- Resource Mining hat EBITDA margin von -869,061.90%
- BelaraRox Ltd hat EBITDA margin von -858,466.20%
- GORE German Office Real Estate AG hat EBITDA margin von -854,792.73%